Literature DB >> 26480673

[Correlation Between Serological Indices and Liver Histological Pathology in Patients with HBV Infection].

Li-yu Chen, Juan Wang, Wei-ya Wang, Hong Tang, Ping Feng.   

Abstract

OBJECTIVE: To analyze the correlation between serological indices and liver histological pathology in the patients with hepatitis B virus ( HBV) infection.
METHODS: This study enrolled 301 patients with HBV infection. All of them received liver biopsy, serum biochemical examination, including alanineamino transferase (ALT), aspart ateaminotransferase (AST), albumin (ALB), globulin (GLB ), HBV DNA test and HBV genotype detection.
RESULTS: ALT, AST and AST/ALT in G2/G(3+4) group were significantly higher than those in group G0/G1 (P < 0.05), and all showed positive correlation with liver inflammation (r = 0.487, 0.648, 0.509, P < 0.05). GLB in S2/S(3+4) group was significantly higher than that in group S0/S1 (P < 0.05), which had positive correlation with liver fibrosis (r = 0.674, P < 0.05). ALB/GLB (A/G) in S2/S(3+4) group was significantly lower than that in group S0/S1 (P < 0.05), it had negative correlation with liver fibrosis(r = -0.500, P < 0.05). The inflammation and fibrosis level in patients with C genotype was higher than that of B genotype (χ2 = 11.460, 12.729, P < 0.05).
CONCLUSION: ALT, AST and AST/ALT show better diagnostic value in liver inflammation. GLB and A/G show better diagnostic value in liver fibrosis. The progress of this disease is relatively faster in the patients with C genotype HBV infection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26480673

Source DB:  PubMed          Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-173X


  1 in total

1.  A promising non-invasive index for predicting liver inflammation in chronic hepatitis B patients with alanine aminotransferase ≤2 upper limit of normal.

Authors:  Xue-Ping Yu; Xiao Wen; Jing Li; Yi-Juan Zheng; Jian-Fei Long; Wei-Dong Zhao; Pei-Xue Jiang; Jing-Wen Wu; Bei-Di Zhu; Qi-Rong Jiang; Fei-Fei Yang; Zhong-Liang Shen; Ri-Cheng Mao; Zhi-Jun Su; Ji-Ming Zhang
Journal:  Exp Ther Med       Date:  2018-09-18       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.